Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004570 · ClinicalTrials.gov registry record

Hereditary Deficits in Auditory Processing Leading to Language Impairment

A clinical trial, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).

Terminated
Registry status
875
Enrollment target

NCT00004570 is a clinical trial that was terminated before completion, run by National Institute on Deafness and Other Communication Disorders (NIDCD). The registered enrollment target is 875 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004570 was terminated before completion, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).

TERMINATED
Registry status
875 participants
Enrollment target

Study Summary

Some children with certain language disorders may not properly process the sounds they hear, resulting in language impairments. The purpose of this study is to determine if deficits in auditory temporal processing the way the brain analyzes the timing and patterns of sounds are an inherited trait. Families with auditory temporal processing deficits are sought in order to identify the genes responsible for auditory temporal processing deficits. Children and adults with a diagnosis or history of language impairment in the family and their family members both affected and non-affected are eligible for this two-part study. In Part 1, participants undergo a series of language tests and listening tests to measure various characteristics of how they perceive sound. In Part 2, they are interviewed about language disorders, learning disabilities, and other medical problems of family members. This information is used to construct a pedigree (family tree diagram) showing the pattern of inheritance of family traits. Study subjects whose pedigree indicates that language disorders may be hereditary in their family will provide either a small blood sample (1 to 2 tablespoons) or a tissue specimen obtained from a cheek swab (rubbing the inside of the cheek with a small brush or cotton swabs). The sample will be used to isolate DNA for genetic analysis.

Trial Details

FieldValue
Enrollment Target 875 participants
Start Date 1999-01-31
Est. Completion 2018-09-18

What the Registry Record Tells You About NCT00004570

The ClinicalTrials.gov registry entry for NCT00004570 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 875 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00004570 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00004570 about?

NCT00004570 is a clinical study titled "Hereditary Deficits in Auditory Processing Leading to Language Impairment". Some children with certain language disorders may not properly process the sounds they hear, resulting in language impairments. The purpose of this study is to determine if deficits in auditory temporal processing the way the brain analyzes the timing and patterns of sounds are an inherited trait. ...

What is the current status of trial NCT00004570?

This trial is currently terminated. The enrollment target is 875 participants. The study started on 1999-01-31. Estimated completion is 2018-09-18.

Who is sponsoring clinical trial NCT00004570?

This trial is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.